21
Participants
Start Date
September 10, 2021
Primary Completion Date
December 31, 2025
Study Completion Date
December 31, 2026
Dupilumab
three q3w cycles
PD-1/PD-L1 blockade
SOC immunotherapy with PD-1/PD-L1 blockade
Anakinra
100 mg daily injection for Three q3w cycles
RECRUITING
Tisch Cancer Institute, Mount Sinai Hospital, New York
WITHDRAWN
The Blavatnik Family-Chelsea Medical Center at Mount Sinai, New York
Thomas Marron
OTHER